Chronic Kidney Disease in Dogs: Welfare Management and Quality of Life

Chronic kidney disease (CKD) is one of the most common conditions in older dogs, causing progressive loss of renal function. Effective management can substantially slow progression and maintain quality of life for affected dogs.

Key Facts

CKD is estimated to affect 0.5-1.5% of all dogs and a much higher proportion of older dogs; it is the most common cause of death in geriatric dogs in some populations.
The kidneys lose function gradually; clinical signs (increased thirst, weight loss, vomiting, lethargy) typically appear only after 75% of renal function has been lost.
The International Renal Interest Society (IRIS) CKD staging system (Stages 1-4) guides treatment intensity and prognosis based on serum creatinine and SDMA levels.
SDMA (symmetric dimethylarginine) is a sensitive biomarker that detects CKD approximately 17 months earlier than creatinine — enabling earlier intervention.
Dietary management with phosphorus restriction and moderated protein is the cornerstone of CKD management; renal diets have been shown to extend survival.
Hypertension is common in dogs with CKD and causes additional organ damage (retinal haemorrhage, cardiac hypertrophy); antihypertensive therapy (amlodipine) is indicated when BP exceeds 160 mmHg.
Proteinuria (protein loss in urine) accelerates renal progression; ACE inhibitors or ARBs reduce proteinuria and slow CKD advancement.
Omega-3 fatty acid supplementation has anti-inflammatory effects in the kidney and may slow CKD progression at appropriate doses.

Welfare Considerations

Dogs with CKD experience a range of welfare-relevant symptoms that accumulate as the disease progresses. Uraemic toxin accumulation causes nausea, vomiting, and profound malaise — the uraemic state is genuinely uncomfortable and reduces quality of life markedly in advanced disease. Anaemia (from reduced erythropoietin production) causes weakness and fatigue. Hypertension may cause sudden vision loss from retinal detachment. Effective management delays these welfare harms: dietary phosphorus restriction significantly slows progression, and treating hypertension and proteinuria reduces the rate of renal function loss. Regular monitoring (every 3-6 months in stable cases) enables early detection of deterioration. Quality-of-life assessment should guide decisions about escalating treatment versus palliative focus in advanced disease.

What You Can Do

Request SDMA measurement alongside routine blood work for dogs over 7 years — early CKD detection enables earlier intervention.
Transition to a veterinary renal diet as soon as CKD is diagnosed — this is the most evidence-based intervention for slowing progression.
Monitor blood pressure every 3-6 months in dogs with CKD — hypertension is common and treatable.
Ensure adequate hydration by encouraging water intake, adding water to food, and discussing subcutaneous fluid therapy with your vet for advanced cases.
Use quality-of-life scoring tools to regularly assess your dog's comfort level and guide decisions about ongoing treatment intensity.